Skip to product information
1 of 1

Aldh5a1 Recombinant Rabbit mAb (S-4135-76)

Aldh5a1 Recombinant Rabbit mAb (S-4135-76)

Catalog Number: S0B60044 Application: WB, IHC-P Reactivity: Hu, Ms, Rt Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen Aldh5a1
Synonyms Succinate-semialdehyde dehydrogenase, mitochondrial; Aldehyde dehydrogenase family 5 member A1; NAD(+)-dependent succinic semialdehyde dehydrogenase; SSADH; ALDH5A1
Immunogen Synthetic Peptide
Location Mitochondrion
Accession P51649
Clone Number S-4135-76
Antibody Type Recombinant mAb
Isotype IgG
Application WB, IHC-P
Reactivity Hu, Ms, Rt
Positive Sample A431, HepG2, Raji, Ramos, mouse brain, mouse liver, rat brain, rat liver, COS-7
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Ms, Rt
IHC-P 1:200 Hu

Background

ALDH5A1 encodes a mitochondrial NAD⁺-dependent succinate semialdehyde dehydrogenase (SSADH), a key enzyme in the catabolic pathway of the neurotransmitter GABA, responsible for the irreversible oxidation of succinate semialdehyde to succinate. Deficiency of this gene leads to a rare autosomal recessive disorder, succinate semialdehyde dehydrogenase deficiency (also known as 4-hydroxybutyric aciduria), in which GABA metabolism is blocked and the neurotoxic metabolite γ-hydroxybutyric acid (GHB) accumulates abnormally, resulting in widespread neurological damage including developmental delay, ataxia, seizures, behavioral disorders, and intellectual disability. Recent studies have revealed that the functional significance of ALDH5A1 extends far beyond its classical metabolic role. In glioblastoma, this gene is significantly downregulated under hypoxic conditions via negative regulation by miR-210, and this downregulation promotes tumor proliferation by reprogramming cellular metabolism and maintaining a high glycolytic phenotype, with low expression closely associated with poor patient prognosis. Conversely, ALDH5A1 overexpression inhibits reactive oxygen species production and shifts cellular metabolism from glycolysis to oxidative phosphorylation, thereby suppressing tumor growth. Additionally, in a mouse model of SSADH deficiency, loss of this enzyme not only impairs GABA metabolism but also leads to astrocyte dysfunction and severe depletion of myelinSphingolipid, suggesting that glial pathology is an important component of the disease mechanism. These findings reposition ALDH5A1 from a conventional metabolic enzyme to a multifunctional regulatory hub linking neurotransmitter metabolism, glial cell function, and tumor metabolic reprogramming.

Picture

Western Blot

WB result of Aldh5a1 Recombinant Rabbit mAb
Primary antibody: Aldh5a1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: U-87 MG whole cell lysate 20 µg
Lane 2: A431 whole cell lysate 20 µg 
Lane 3: HepG2 whole cell lysate 20 µg
Lane 4: Raji whole cell lysate 20 µg 
Lane 5: Ramos whole cell lysate 20 µg
Low expression control: U-87 MG whole cell lysate
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 57 kDa
Observed MW: 55 kDa

WB result of Aldh5a1 Recombinant Rabbit mAb
Primary antibody: Aldh5a1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: mouse brain lysate 20 µg
Lane 2: mouse liver lysate 20 µg 
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 57 kDa
Observed MW: 50 kDa

WB result of Aldh5a1 Recombinant Rabbit mAb
Primary antibody: Aldh5a1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: rat brain lysate 20 µg
Lane 2: rat liver lysate 20 µg 
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 57 kDa
Observed MW: 50 kDa

WB result of Aldh5a1 Recombinant Rabbit mAb
Primary antibody: Aldh5a1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: COS-7 whole cell lysate 20 µg
Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 57 kDa
Observed MW: 55 kDa

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human kidney. Anti-Aldh5a1 antibody was used at 1/200 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human liver. Anti-Aldh5a1 antibody was used at 1/200 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human colon cancer. Anti-Aldh5a1 antibody was used at 1/200 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human liver cancer. Anti-Aldh5a1 antibody was used at 1/200 dilution, followed by a HRP Polymer for Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.